Ya who wouldn’t want to miss out on the chance to see Cytodyn, like Red Hat (acquired for $34 billion after a mere $2 billion valuation), Monster Beverage (from $0.50 to $4.6 billion with Coca-Cola), and Juno Therapeutics (jumping from $1 billion to a $9 billion acquisition by Celgene), explode to a billion-dollar valuation just from a sneeze or rumor?

I tend to agree with your stance, however it’s not too far off from reality.

First announce partnership, which would send this into multi billon dollar market cap. Then a year later some data to support a 20 billon dollar offer. IMMU basically 20X in a matter of 8 months I remember because I was invested.

So no we wouldn’t be the first and we won’t be the last.